Page 1 of Clinical Trials for Galantamine tablet, 10 Total Matches
- 1CompletedLast Updated: May 18, 2011Condition(s): Pharmacokinetics
- 2CompletedLast Updated: May 18, 2011Condition(s): Alzheimer Disease
- 3CompletedLast Updated: August 27, 2010Condition(s): Healthy
- 4CompletedLast Updated: August 27, 2010Condition(s): Healthy
- 5CompletedLast Updated: June 29, 2011Condition(s): Fasting
- 6CompletedLast Updated: June 29, 2011Condition(s): Fed
- 7RecruitingLast Updated: May 4, 2012Condition(s): Biomarkers, Pharmacological
- 8CompletedLast Updated: May 15, 2009Condition(s): Schizophrenia; Schizoaffective Disorder
- 9CompletedLast Updated: March 22, 2012Condition(s): Alzheimer's Disease
- 10Active, not recruitingLast Updated: November 8, 2010Condition(s): Alzheimer's Disease
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Galantamine+tablet
